Evidence map›Paper›PMID 25310979›Full record

ArticleCell reports2014

A conserved proline triplet in Val-tRNA synthetase and the origin of elongation factor P.

Agata L Starosta, Jürgen Lassak, Lauri Peil, Gemma C Atkinson, Christopher J Woolstenhulme, Kai Virumäe, Allen Buskirk, Tanel Tenson, Jaanus Remme, Kirsten Jung and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Translation factors that keep the ribosome Pro-active.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. YfmR is a translation factor that prevents ribosome stalling and cell death in the absence of EF-P.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Translation elongation factor P (EF-P).FEMS microbiology reviews · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Agata L StarostaGene Center and Department for Biochemistry, University of Munich, Feodor-Lynen-Straße 25, 81377 Munich, Germany.
Jürgen LassakDepartment of Biology I, Microbiology, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany.
Lauri PeilWellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH8 9YL, UK; Institute of Technology, University of Tartu, Tartu 50090, Estonia.
Gemma C AtkinsonInstitute of Technology, University of Tartu, Tartu 50090, Estonia; Department of Molecular Biology and Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå 901 87, Sweden.
Christopher J WoolstenhulmeDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Kai VirumäeInstitute of Molecular and Cell Biology, University of Tartu, Tartu 50090, Estonia.
Allen BuskirkDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Tanel TensonInstitute of Technology, University of Tartu, Tartu 50090, Estonia.
Jaanus RemmeInstitute of Molecular and Cell Biology, University of Tartu, Tartu 50090, Estonia.
Kirsten JungDepartment of Biology I, Microbiology, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany; Center for Integrated Protein Science Munich (CiPSM) at the University of Munich, 80539 Munich, Germany.
Daniel N WilsonGene Center and Department for Biochemistry, University of Munich, Feodor-Lynen-Straße 25, 81377 Munich, Germany; Center for Integrated Protein Science Munich (CiPSM) at the University of Munich, 80539 Munich, Germany. Electronic address: wilson@lmb.uni-muenchen.de.
University of Tartu · EEBrigham Young University · USCenter for Integrated Protein Science Munich · DELudwig-Maximilians-Universität München · DEUmeå University · SE

Funding

Genetic studies on bacterial trans-translationR01GM077633 · NIGMS · BRIGHAM YOUNG UNIVERSITY · PI BUSKIRK, ALLEN ROWDON · 2006 to 2010
$1.3M
The Mechanism of Pausing and Restarting Translation in BacteriaR01GM110113 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BUSKIRK, ALLEN ROWDON · 2014 to 2017
$1.2M
NIGMS NIH HHS R01 GM077633NIGMS NIH HHS R01 GM110113
6 · The paper itself

Abstract

Bacterial ribosomes stall on polyproline stretches and require the elongation factor P (EF-P) to relieve the arrest. Yet it remains unclear why evolution has favored the development of EF-P rather than selecting against the occurrence of polyproline stretches in proteins. We have discovered that only a single polyproline stretch is invariant across all domains of life, namely a proline triplet in ValS, the tRNA synthetase, that charges tRNA(Val) with valine. Here, we show that expression of ValS in vivo and in vitro requires EF-P and demonstrate that the proline triplet located in the active site of ValS is important for efficient charging of tRNA(Val) with valine and preventing formation of mischarged Thr-tRNA(Val) as well as efficient growth of E. coli in vivo. We suggest that the critical role of the proline triplet for ValS activity may explain why bacterial cells coevolved the EF-P rescue system.

Indexed as

Conserved SequenceAmino Acid SequenceEscherichia coliEscherichia coli ProteinsEvolution, MolecularMolecular Sequence DataMutationPeptide Elongation FactorsPeptidesValine-tRNA LigaseEscherichia coli Proteinsfactor EF-PPeptide Elongation FactorsPeptidespolyprolineValine-tRNA Ligase

Identifiers

PMID25310979
PMCPMC4847715
OpenAlexW1996696804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.